Beta Drugs Valuation
| BETA Stock | 1,660 17.00 1.03% |
Beta Drugs shows a prevailing Real Value of USD1560.4 per share. The current price of the firm is USD1660.0. Our model approximates the value of Beta Drugs from analyzing the firm technical indicators and probability of bankruptcy. In general, investors favor acquiring undervalued stocks and selling overvalued stocks since, at some point, stock prices and their ongoing real values will blend.
Beta Drugs Total Value Analysis
Beta Drugs is currently projected to have takeover price of 0 with market capitalization of 0, debt of , and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Beta Drugs fundamentals before making investing decisions based on enterprise value of the companyBeta Drugs Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The newest return on assets of Beta implies not a very effective usage of assets in February.About Beta Drugs Valuation
The stock valuation mechanism determines Beta Drugs' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Beta Drugs based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Beta Drugs. We calculate exposure to Beta Drugs's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Beta Drugs's related companies.Additional Tools for Beta Stock Analysis
When running Beta Drugs' price analysis, check to measure Beta Drugs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Beta Drugs is operating at the current time. Most of Beta Drugs' value examination focuses on studying past and present price action to predict the probability of Beta Drugs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Beta Drugs' price. Additionally, you may evaluate how the addition of Beta Drugs to your portfolios can decrease your overall portfolio volatility.